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In this paper, we analyze the temporal evolution of the age-dependent force of infection and
incidence of rubella, after the introduction of a very specific vaccination programme in a previ-
ously nonvaccinated population where rubella was in endemic steady state. We deduce an integral
equation for the age-dependent force of infection, which depends on a number of parameters that
can be estimated from the force of infection in steady state prior to the vaccination program. We
present the results of our simulations, which are compared with observed data. We also examine
the influence of contact patterns among members of a community on the age-dependent intensity
of transmission of rubella and on the results of vaccination strategies. As an example of the the-
ory proposed, we calculate the effects of vaccination strategies for four communities from Caieiras
(Brazil), Huixquilucan (Mexico), Finland and the United Kingdom. The results for each community
differ considerably according to the distinct intensity and pattern of transmission in the absence of
vaccination. We conclude that this simple vaccination program is not very efficient (very slow) in
the goal of eradicating the disease. This gives support to a mixed strategy, proposed by Massad et
al., accepted and implemented by the government of the State of Sa˜o Paulo, Brazil.
PACS numbers: 87.10.+e, 87.19.Xx
I. INTRODUCTION
The control of directly transmitted, viral childhood in-
fections, around the globe has been strongly dependent
on vaccination, the most effective control tool developed
so far [1]. There are several infections for which vac-
cines exist. These are therefore candidates for eradica-
tion. Some examples include polio, measles and rubella,
just to mention a few. Vaccination strategies, however,
have been each time more dependent on inferences based
on quantitative models, which can, through simulation
tools, yield distinct scenarios and possibilities. These
simulation techniques, in turn, have been proved to be
invaluable tools for helping health authorities to decide
between competitive strategies of eradication or control
of those infections.
In previous publications [2, 3], we applied mathemati-
cal models to design and to evaluate the impact of vacci-
nation against rubella in the state of Sa˜o Paulo, Brazil.
Rubella is a viral infection that causes a mild disease,
but it is considered to be a public health problem due
to the risk of fetal infection and subsequent congenital
defects [2, 4, 5]. Therefore, the goal of rubella vaccina-
tion is to prevent from the congenital rubella syndrome
(CRS). Plotkin [5] argues that, due to the high prevalence
of rubella in some countries, only high vaccine coverage
would avoid the increase of CRS.
In this paper, we analyse the effects of different con-
∗Author for correspondence. E-mail: amaku@vps.fmvz.usp.br
tact patterns on vaccination strategies against rubella in
some communities. We investigate a plausible form for
the contact rate function including some constrains it
must satisfy. We concentrate on the integral equation
for the age-dependent force of infection — defined as the
age-dependent number of new infections per capita, per
unit time —, which relates the pattern of contacts among
the members of a population with the prevalence of the
disease, following a methodology developed elsewhere [6].
The basic idea is to examine the force of infection in
steady state that results from a given vaccination strat-
egy.
We also turn our attention to the dynamics of the
process, following the time development of the age-
dependent force of infection when a vaccination strategy
is started at a certain time t in a previously nonimmu-
nized population. Some aspects of the age and time de-
pendences in epidemic models have already been studied
by some authors (e.g., [7, 8]).
This paper is organized as follows. In Sec. II, we
present the formalism used. We describe in detail how
the contact rate function is related to the force of infec-
tion, discuss some constrains it must satisfy, and propose
a form for it. In Sec. III, we describe the fitting proce-
dures adopted to determine the values of the parameters
of the contact rate function for different communities.
In Sec. IVA, we analyse the impact of specific vaccina-
tion strategies against rubella using data from commu-
nities from Caieiras, a Brazilian small town located in
the neighbourhoods of Sa˜o Paulo city (Azevedo Neto et
al. [4]), Huixquilucan, Mexico (Golubjatnikov et al. [9]),
Finland (Edmunds et al. [10]) and the United Kingdom
2(Farrington et al. [11]). It must be noted that the results
from Brazil and Mexico are from nonvaccinated commu-
nities, while the results from Finland and the United
Kingdom are from nonvaccinated males in communitites
that have partially vaccinated female population [11, 12].
The results from Sa˜o Paulo will be compared with those
previously reported by Massad et al. [2, 13]. This paper
differs from those quoted above, in that the form of the
contact rate function, representing the age related pat-
tern of contacts, was studied more carefully. Also the
relation between the vaccination rate ν and the result-
ing proportion of vaccinated people [see Eqs. (46)-(47)]
was modified. In spite of this, as we shall see, the rec-
ommended vaccination strategy was maintained, but the
calculated effects of the vaccination strategies seem now
to be more realistic. In Sec. IVB, we present simulations
of the temporal evolution of the force of infection and, in
Sec. IVC, we compare our results to experimental re-
sults. Finally, in Sec. V, we summarize our results.
II. MATHEMATICAL DEVELOPMENTS
A. Temporal Evolution
Let us assume a SIR model (Susceptible–Infected–
Recovered). Let S(a, t)da, I(a, t)da, and R(a, t)da be,
respectively, the number of susceptible, infected and non-
susceptibles (including recovered and vaccinated) indi-
viduals with ages between a and a + da at time t. We
can write
∂S(a, t)
∂a
+
∂S(a, t)
∂t
= −[λ(a, t) + ν(a, t) + µ]S(a, t)
∂I(a, t)
∂a
+
∂I(a, t)
∂t
= λ(a, t)S(a, t)− (µ+ γ)I(a, t) (1)
∂R(a, t)
∂a
+
∂R(a, t)
∂t
= ν(a, t)S(a, t) + γI(a, t)− µR(a, t) ,
where ν(a, t) is the age and time-dependent rate of vacci-
nation, γ is the recovery rate, and µ is the mortality rate,
assumed constant. This type of mortality rate (constant)
is known as type-II mortality function. Another type of
survival curve (type I) considers that all individuals sur-
vive to exactly a certain age, and then die. Anderson
and May [14] mention that, for both developed and de-
veloping countries, the observed mortality function is in-
termediate between type I and type II, although closer
to type I for developed regions.
The definition of the force of infection, as a function of
age and time, is
λ(a, t) =
∫
∞
0
da′β(a, a′)
I(a′, t)
N(a′, t)
, (2)
andN(a, t) = S(a, t)+I(a, t)+R(a, t) is the total number
of individuals whose ages are between a and a+da at time
t. In this equation, β(a, a′) is the so-called contact rate
function. It is defined so that β(a, a′)dada′ is the number
of contacts a person with age between a and a+da makes
with all persons with age between a′ and a′+da′ per unit
time. Therefore, β(a, a′) describes the contact patterns
among the members of a population.
Taking into account the three equations of system (1),
we can write, for N(a, t),(
∂
∂a
+
∂
∂t
)
N(a, t) = −µN(a, t) . (3)
For simplicity, we consider that, at time t, the total
population has size N . In other words, we have taken
N(a, t) = N(a) = N(0)e−µa, for a given t. In this equi-
librium situation, the mortality rate equals the natality
rate, and we have N(0) = µN.
1. Integral equation for λ(a, t)
Applying the method of the characteristics, as pro-
posed by Trucco [15] (see also [16]) for solving the
McKendrick-Von Foerster equation, we can solve the sys-
tem of equations (1).
Let s(a, t) and i(a, t) be the proportions of susceptible
and infected individuals, among those with age a at time
t, given by
s(a, t) =
S(a, t)
N(a, t)
, i(a, t) =
I(a, t)
N(a, t)
. (4)
With these previous definitions, the first two equations
of the partial differential equations system (1) can also
be written as follows:
∂s(a, t)
∂a
+
∂s(a, t)
∂t
= −[λ(a, t) + ν(a, t)]s(a, t) (5)
∂i(a, t)
∂a
+
∂i(a, t)
∂t
= λ(a, t)s(a, t)− γi(a, t) . (6)
The boundary conditions are such that, at age a = 0,
for t ≥ 0, we have s(0, t) = 1 and i(0, t) = 0. At time
t = 0, for a ≥ 0, we have that s(a, 0) and i(a, 0) are
functions of age. In the calculations, the upper limit for
the age is taken to be L = 60 yr.
Considering the change of variables (as those proposed
by Trucco [15])
ξ = a− t
η = t
we have
s(a, t) = s(ξ + η, η) = s′(ξ, η)
and similarly for i(a, t), λ(a, t) and ν(a, t).
We also have that (∂/∂a+∂/∂t) = ∂/∂η. Thus, taking
into account the above mentioned change of variables,
Eq. (5) reads
∂
∂η
ln s′(ξ, η) = −[λ′(ξ, η) + ν′(ξ, η)] , (7)
3whose generic solution can be written as
ln s′(ξ, η) = −
∫ η
p
[λ′(ξ, x) + ν′(ξ, x)]dx + f(ξ) , (8)
where p and f(ξ), parameters related to the boundary
conditions, are given by
f(ξ) = ln s′(ξ, 0) , p = 0 (9)
f(ξ) = ln s′(ξ,−ξ) , p = −ξ . (10)
for ξ > 0 and ξ < 0, respectively.
Then, for the cases in which ξ > 0 (a > t) or ξ < 0
(a < t), we have, respectively, the following solutions:
ξ > 0 : s′(ξ, η) = s′(ξ, 0) e
−
∫
η
0
[λ′(ξ,x)+ν′(ξ,x)] dx
(11)
ξ < 0 : s′(ξ, η) = s′(ξ,−ξ) e
−
∫
η
−ξ
[λ′(ξ,x)+ν′(ξ,x)]dx
.(12)
Rewriting the equations above in terms of a and t, we
obtain
s(a, t) = s(a− t, 0) exp
[
−
∫ t
0
[λ(a − t+ x, x)
+ ν(a− t+ x, x)] dx
]
(13)
s(a, t) = s(0, t− a) exp
[
−
∫ t
t−a
[λ(a − t+ x, x)
+ ν(a− t+ x, x)] dx
]
=
= s(0, t− a) exp
[
−
∫ a
0
[λ(z, z − a+ t)
+ ν(z, z − a+ t)] dz
]
. (14)
for a > t and t > a, respectively.
Equation (6)(
∂
∂a
+
∂
∂t
)
i(a, t) + γi(a, t) = λ(a, t)s(a, t) (15)
can be rewritten, with the change of variables, as
∂
∂η
i′(ξ, η) + γi′(ξ, η) = λ′(ξ, η)s′(ξ, η) , (16)
whose solution is
i′(ξ, η) = e
−
∫
η
q
γds
[∫ η
q
dxλ′(ξ, x)s′(ξ, x)e
∫
x
q
γds
+g(ξ)
]
,
(17)
where q and g(ξ) depend on the boundary conditions:
g(ξ) = i′(ξ, 0) , q = 0 (18)
g(ξ) = i′(ξ,−ξ) , q = −ξ . (19)
for ξ > 0 and ξ < 0, respectively.
Equation (17), in terms of a and t, is given by
i(a, t) =
∫ t
0
dt′ λ(a− t+ t′, t′)s(a− t, 0)α(a, t, t′) +
+ e−γti(a− t, 0), a > t, (20)
i(a, t) =
∫ a
0
da′ λ(a′, a′ − a+ t)s(0, t− a)ψ(a, t, a′) +
+ e−γai(0, t− a), a < t, (21)
where α(a, t, t′) and ψ(a, t, a′) are
α(a, t, t′) = e
−
∫
t′
0
[λ(a−t+τ,τ)+ν(a−t+τ,τ)]dτ
eγ(t
′
−t) (22)
and
ψ(a, t, a′) = e
−
∫
a′
0
[λ(z,z−a+t)+ν(z,z−a+t)]dz
eγ(a
′
−a) .
(23)
The age and time-dependent force of infection [Eq. (2)]
can also be written as
λ(a, t) =
∫
∞
0
da′β(a, a′)i(a′, t) . (24)
In the calculations, as already explained, the upper
limit of the above integral is taken to be L = 60 yr.
Thus, replacing solutions (20) and (21) for i(a, t) in the
above definition, and considering that age is in the in-
terval 0 ≤ a ≤ L, the integral equation for the age and
time-dependent force of infection is given by
λ(a, t) =
∫ min(t,L)
0
da′ β(a, a′)
∫ a′
0
da′′ λ(a′′, a′′ − a′ + t)
× ψ(a′, t, a′′) + θ(L − t)
∫ L
t
da′ β(a, a′)
×
[∫ t
0
dt′ λ(a′ − t+ t′, t′)s(a′ − t, 0)α(a′, t, t′)
+ e−γt i(a′ − t, 0)
]
, (25)
where θ(L− t) is the Heaviside function. In the following
section, we study the steady state of Eq. (25).
2. Steady state behavior
Let S(a)da be the number of susceptible individuals
with age between a and a + da. The fraction of poten-
tially infectious contacts they make with actually infec-
tives aged between a′ and a′ + da′ per unit time is
S(a)daβ(a, a′)da′
I(a′)
N(a′)
. (26)
4The total number of potentially infective contacts of
susceptibles aged between a and a + da with infectives
can be obtained by integrating Eq. (26) in da′. Then,
we obtain an expression for the age-dependent force of
infection similar to Eq. (24).
Equation (21) in the steady state condition gives
i(a) = e−γa
[∫ a
o
da′eγa
′
λ(a′)s(0)
× e
−
∫
a′
0
dz[λ(z)+ν(z)]
+ i(0)
]
. (27)
Substituting this expression in the definition of the age-
dependent force of infection in steady state we have
λ(a) =
∫
∞
0
da′β(a, a′)
∫ a′
0
da′′e−γ(a
′
−a′′)λ(a′′)
× e
−
∫
a′′
0
dz[λ(z)+ν(z)]
. (28)
The integral equation (28) always has λ(a) = 0 as solu-
tion. According to Lopez and Coutinho [17], depending
on the parameters of the integral equation, it may have
another unique positive solution.
Equation (28) is the limit for large t of Eq. (25):
λ(a) = lim
t→∞
λ(a, t) .
B. Contact Patterns
1. Symmetry in the contact pattern
As mentioned in the Introduction, one of our main diffi-
culties is to choose a correct form for the contact function
β(a, a′). In this section, we analyze a specific situation in
which β(a, a′) has to satisfy a symmetry relation that
restricts its form: if a person A has a contact with a
person B, then B had a contact with A. In terms of
transmission dynamics, it means that the total number
of contacts a group C of infected individuals make with
a group D of susceptibles equals the number of contacts
group D had with group C. This symmetry is relevant
when a direct, person-to-person contact is required for
transmission. For instance, a direct contact is required
for sexually transmitted diseases. It seems to be at least
partially required for the transmission of directly trans-
mitted childhood diseases such as rubella.
The number of contacts the susceptibles with age be-
tween a and a+damake with infectives with age between
a′ and a′+ da′, in a time interval ∂t, is, as we have seen,
S(a)daβ(a, a′)da′
I(a′)
N(a′)
∂t . (29)
This number must be equal to the number of contacts
the infectives with age between a′ and a′+da′ make with
the susceptibles with age between a and a + da. This
number is
I(a′)da′β(a′, a)da
S(a)
N(a)
∂t . (30)
Thus, we must have
S(a)β(a, a′)
I(a′)
N(a′)
= I(a′)β(a′, a)
S(a)
N(a)
(31)
or
β(a, a′)
N(a′)
=
β(a′, a)
N(a)
. (32)
Since N(a) = N(0)e−µa, we see that Eq. (32) is satis-
fied if β(a, a′) has the form
β(a, a′) = eµah(a, a′) , (33)
where h(a, a′) is symmetric, that is
h(a, a′) = h(a′, a) . (34)
Equation (33) will be used in the following section to
construct an analytical form for β(a, a′).
2. A form for the contact function β(a, a′)
Let us consider that rubella is approximately trans-
mitted by direct person-to-person contact. In this case,
considering that children are stratified mainly by age in
classrooms [3], it is reasonable to assume that contacts
are more intense among children with the same age. It
is then convenient to write h(a, a′) as a product of two
functions,
h(a, a′) = f(a, a′)g(a, a′) . (35)
The function f(a, a′) represents the longitudinal profile of
h(a, a′) along the plane a = a′ and g(a, a′) the transversal
profile related to the spread of h(a, a′) to both sides of
the plane a = a′.
We have chosen the following positively skewed func-
tion for f(a, a′)
f(a, a′) = b1(a+ a
′)e−b2(a+a
′) , (36)
and a Gaussian-like function for g(a, a′)
g(a, a′) = e−(a−a
′)2/σ2 , (37)
where σ = σ(a, a′) is related to the width of the
Gaussian-like distribution to the sides of a = a′. Consid-
ering a linear spread
σ(a, a′) = b3 + b4(a+ a
′) , (38)
we obtain
h(a, a′) = b1(a+ a
′)e−b2(a+a
′)e−(a−a
′)2/[b3+b4(a+a
′)]2 ,
(39)
5where b1, b2, b3 e b4 are the parameters to be determined.
Thus, taking into account Eq. (33), we have, for the
contact function β(a, a′),
β(a, a′) = b1(a+ a
′)e−b2(a+a
′)e−(a−a
′)2/[b3+b4(a+a
′)]2eµa .
(40)
Other functions could be chosen for h(a, a′), as those
proposed in Coutinho et al. [6] and Massad et al. [3].
C. The relationship between vaccination rate and
vaccine coverage
For our next simulations, we need to define what we
mean by vaccination routine. In a nutshell, we take
ν(a, t) = νθ(a− a0)θ(a1 − a)θ(t− t0) , (41)
which has the following interpretation: after time t0
years, children are vaccinated at a constant rate of ν
children per unit of time when their ages are between
a0 and a1. In practice, the government usually informs
through the media that mothers should take their chil-
dren to health centers to receive the shots. The response
of parents to the government advertisement results in a
given ν. Enthusiastic response results in a high ν.
In steady state, Eq. (41) becomes
ν(a) = νθ(a − a0)θ(a1 − a) . (42)
We shall now calculate the relationship between ν and
resulting proportion of vaccine coverage, p. Let V (a)da
be the number of vaccinated individuals with age be-
tween a and a+ da. Let Nv(a)da be the number of non-
vaccinated persons with age between a and a + da. We
have
dV (a)
da
= ν(a)Nv(a)− µV (a) (43)
dNv(a)
da
= −ν(a)Nv(a)− µNv(a) . (44)
Of course, we have V (a) +Nv(a) = N(a).
Solving Eq. (43) using the form of ν(a) given by Eq.
(42), we have
V (a) =


0 ,
N(0)e−µa[1− e−ν(a−a0)] ,
N(0)e−µa[1− e−ν(a1−a0)] ,
a < a0
a0 ≤ a ≤ a1
a > a1
.
(45)
The proportion p of vaccine coverage is defined as
p =
V (a1)
N(a1)
= 1− e−ν(a1−a0) . (46)
The inverse relation between ν and p is
ν =
ln(1− p)
a0 − a1
. (47)
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FIG. 1: Seroprevalence data and corresponding fitted curves
for communities from Brazil, Mexico, Finland and the UK.
The data for Caieiras (Brazil), Huixquilucan (Mexico), Fin-
land and the UK were taken, respectively, from the works of
Azevedo Neto et al. [4], Golubjatnikov et al. [9], Edmunds et
al. [10] and Farrington et al. [11].
III. FITTING THE MODEL TO THE DATA
Data consisted in seroprevalence studies carried out in
communities from Mexico, Brazil, Finland and the UK.
Let S+(a)da be the proportion of seropositive individ-
uals to rubella — whose serological tests were positive,
indicating that they have already been infected — with
ages between a and a+ da. An estimate of the function
S+(a) resulted from fitting the serological data to (see
Ref. [18])
S+(a) = 1− exp
{
k1
k22
[
(k2a+ 1) e
−k2a − 1
]}
, (48)
where ki (i = 1, 2) are fitting parameters, estimated by
the maximum likelihood technique for all the communi-
ties except that from Finland, which was estimated by
the least squares fitting technique. Figure 1 shows the
results of the fitting functions for the four communities
considered, and the fitting parameters are shown in Table
I.
In our model, the seropositive individuals correspond
to those who are either infected or nonsusceptibles (re-
covered and vaccinated), i.e., the proportion of seroposi-
tives, S+(a), is equivalent to 1− s(a). The force of infec-
tion in the absence of vaccination, λ0(a), was estimated
from the seroprevalence data by the so-called catalytic
approach (e.g., Ref. [19]), according to
λ0(a) =
dS+(a)
da
(
1− S+(a)
)
−1
. (49)
6The term catalytic arises from an analogy with chem-
istry. In the dynamics of infectious diseases, an infected
individual would act as a catalyst, infecting susceptible
individuals. Equation (49) corresponds to Eq. (5) in
the steady state for the susceptible individuals, in the
absence of vaccination.
Equation (49), expressed in terms of Eq. (48), results
in
λ0(a) = k1a exp [−k2a] . (50)
The values of the parameters of the contact function
β(a, a′) [Eq. (40)] were calculated so that the resulting
force of infection λ(a), in the absence of vaccination, ob-
tained by solving Eq. (28) iteratively, agreed with λ0(a)
given by Eq. (50). The parameters γ and µ were taken,
respectively, to be 26.0 yr−1, corresponding to an infec-
tious period of 2 weeks, and 0.017yr−1, the inverse of a
life expectancy of 60 yr. Those parameters were taken
to be the same for all communities, for simplicity. The
resulting parameters of the contact function β(a, a′) for
each community considered are shown in Table I.
For Finland and the UK, we carried out simulations
considering the two types of mortality functions de-
scribed in Sec. II A. As the results were very similar,
we discuss only those concerning type-II mortality rate.
TABLE I: Fitting parameters (k1 and k2) of the seropreva-
lence function, and the parameters of the contact function,
for each community considered.
Community k1(yr
−2) k2(yr
−1) b1(yr
−2) b2(yr
−1) b3(yr) b4
Brazil 0.0456 0.108 0.658 0.0468 3.49 0.341
Mexico 0.214 0.255 3.54 0.116 1.04 0.416
Finland 0.0290 0.1068 0.587 0.0608 2.77 0.398
UK 0.0833 0.1804 1.60 0.0928 1.747 0.391
The forces of infection [as given by Eq. (50)] for the
same communities are shown in Fig. 2. As can be noted,
the curves have strikingly different shapes, reflecting dis-
tinct contact patterns. As we shall see later, this has
profound impact on the calculated efficacy of different
vaccination strategies.
From the force of infection, we can define the average
age at which susceptibles acquire infection
a =
∫
∞
0 aλ(a)s(a)da∫
∞
0 λ(a)s(a)da
. (51)
We have taken the highest ages observed in the seroepi-
demiological studies as the upper integration limits of
the integrals of Eq. (51). The calculated values for the
communities studied are given in the Table II below.
The contact functions β(a, a′) [Eq. (40)] of the com-
munities considered are shown in Fig. 3 as examples of
the general shape obtained. The analysis of these contact
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FIG. 2: Force of infection for the communities studied derived
from equation (50).
TABLE II: Average age at infection for the four communities
studied.
Community a (yr)
Caieiras, Brazil 8.45
Huixquilucan, Mexico 3.96
Finland 10.6
UK 6.64
functions suggests two distinct patterns. In Mexico and
in the United Kingdom, the age distribution of contacts is
concentrated at lower ages. In contrast, the communities
of Caieiras and Finland show a broader range of contacts,
spread over all ages. In addition, it can be noted that
the density of contacts estimated for the communities of
Mexico and Caieiras are roughly twice as high as in the
United Kingdom and Finland, respectively. This may re-
flect distinct social contexts between the developed and
developing countries as well as the fact that data from
developed communities are only for males in communi-
ties which have partially vaccinated female populations
[11, 12].
IV. SIMULATION RESULTS
A. Effects of specific vaccination strategies
We now calculate the results of specific vaccination
strategies in the above mentioned communities, choosing
a0 = 1 year and a1 = 2 years, a0 = 7 years and a1 = 8
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FIG. 3: Calculated values of the contact functions β(a, a′) and respective contour plots for: (a) Caieiras, Brazil; (b) Mexico;
(c) Finland; and (d) the United Kingdom.
years, and a0 = 14 years and a1 = 15 years for several
values of ν. For a given vaccination coverage proportion
p, we determine ν through Eq. (47).
The simulated results of the vaccination strategies were
obtained by solving Eq. (28) using the values of the pa-
rameters of β(a, a′) obtained in Sec. III for the vaccina-
tion strategies described above.
The results for the communities of Brazil and Finland
are shown, respectively, in Figures 4 and 5. The results
for Mexico and UK are not shown in graphs, but we have
discussed them below. Figure 4 shows the results of vacci-
nation strategies applied to the community of Sa˜o Paulo.
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FIG. 4: Effects of different vaccination programs calculated
for Caieiras, Brazil. Children are vaccinated (a) between 1
and 2 yr , (b) between 7 and 8 yr, and (c) between 14 and
15 yr. The numbers above the dashed lines indicate the cor-
responding vaccine coverage and the solid lines correspond to
the catalytic model. In graph (c), the dashed lines correspond,
respectively, to 0.0, 0.4, 0.8 and 0.97 vaccine coverages.
Figures 4(a)–4(c) represent the different age intervals of
vaccination. It can be noted that 75% coverage in the
age interval from 1 to 2 yr almost eliminates the disease,
but the peak of infection is shifted to around 17 yr, and
therefore it is displaced to the right as compared with
the case of no vaccination. A coverage between 79% and
80% eliminates the disease. In Fig. 4(b), it can be noted
that 85% coverage in the age 7–8 yr almost eliminates the
disease. In addition, the peak of infection occurs around
8 yr, and therefore it is displaced to the left as compared
with the case of no vaccination. A 90% coverage in this
age interval eliminates the disease. Finally, Figure 4(c)
shows that vaccination in the interval from 14 to 15 yr is
almost useless, since 97% coverage has very little impact
in the force of infection, and it is impossible to eliminate
the disease, even if a 100% coverage is used.
Figure 5 shows the results of vaccination strategies ap-
plied to the community in Finland. Figures 5(a)–5(c)
represent the different age intervals of vaccination. It
can be noted that 60% coverage in the age interval 1–2
yr [Fig. 5(a)] almost eliminates the disease, and the age
of the peak of infection is not affected at all. A cover-
0 10 20 30 40 50 600.00
0.04
0.08
0.12
0.7
0.6
0.4
0.2
0.0
λ(a
) (
yr
-
1 )
0 10 20 30 40 50 600.00
0.04
0.08
0.12
(c)
(b)
(a)
 
 Age (years)
0 10 20 30 40 50 600.00
0.04
0.08
0.12
0.4
0.2
0.6
0.0
FIG. 5: Effects of different vaccination programs calculated
for Finland. Children are vaccinated (a) between 1 and 2
yr, (b) between 7 and 8 yr and (c) between 14 and 15 yr.
The numbers over the dashed lines indicate the corresponding
vaccine coverage and the solid lines correspond to the catalytic
model. In graph (c), the dashed lines correspond, respectively,
to 0.0, 0.4, 0.8 and 0.97 vaccine coverages.
age of 64% eliminates the disease. In Fig. 5(b), it can be
noted that 70% coverage in the age interval 7–8 yr almost
eliminates the disease, and again does not shift the age
of the peak in the force of infection. Finally, Fig. 5(c)
shows that vaccination in the interval from 14 to 15 yr is
almost useless, since 97% coverage has very little impact
on the force of infection, and it is impossible to eliminate
the disease even if a 100% coverage is used.
For the Huixquilucan community in Mexico a 74% cov-
erage in the age interval 1–2 yr eliminates the disease.
Even a 97% coverage in the age interval 7–8 yr is not
able to eliminate the disease, and indeed causes very lit-
tle effect on its force of infection.
For the community in the UK, a 66% coverage in the
age interval 1–2 yr eliminates the disease. Even a 97%
coverage in the age interval 7–8 yr is not able to eliminate
the disease. However, the peak of the force of infection
curve shifts leftwards to around 5 yr.
As expected, the results of vaccinating in the inter-
val from 7 to 8 yr of age are disappointing if compared
to the results of vaccinating from 1 to 2 yr of age, and
vaccinating between 14 and 15 yr is almost useless.
9Vaccination programmes against rubella were imple-
mented in many countries (e.g., Refs. [2, 10, 12, 13,
20, 21]). However, vaccination coverages and strategies
sometimes changed from one period to another. As men-
tioned by Ukkonen [12], UK (1970) and Finland (1975)
chose selective vaccination of 11- and 13-year-old girls to
prevent rubella and such a strategy was not effective in
eradicating the virus. These observed results agree with
our simulation for vaccination from 14 to 15 yr of age.
In 1998, rubella vaccine was introduced in Mexico into
the childhood vaccination schedule at age 1 and 6 yr [21],
resulting in an intense decrease in the rubella incidence,
in agreement with our simulations for vaccination from 1
to 2 yr of age.
B. Temporal evolution
The simulations for the temporal evolution of the force
of infection were based on the numerical solutions of
the integral equation for λ(a, t), using the parameters
of β(a, a′) for the Caieiras community.
Our first simulation considered a completely suscepti-
ble population (which is not the case with Caieiras). We
then assumed that, at time t = 0, a proportion pi = 10
−5
of individuals with ages between 40 and 45 yr suddenly
become infected. The resulting dynamics of the disease
is shown in Fig. 6.
It can be noted that after a few oscillations the force
of infection tends to the function λ0(a). We can also see
that from around 40 yr onwards the force of infection
stabilizes. Figure 7 displays a profile cut at 8 yr old.
For our next simulation, the same conditions as the
above simulation were applied, and a vaccination routine
of form (41) with a0 = 1 yr, a1 = 2 yr, t0 = 40 yr, and a
vaccination coverage of 70% was added. The results for
all ages are shown in Fig. 8. It can be noted that after
the introduction of the vaccination, the force of infection
oscillates before reaching a steady state, much lower than
λ0(a). The whole process takes around 40 yr to reach
the new steady state. The fact that the process takes
so long to reach a steady state does not recommend this
vaccination strategy for eradicating the disease.
The next simulation uses the same vaccination scheme,
but with a vaccination coverage of 80%. The results for
all ages are shown in Fig. 9.
For this coverage one can see that the disease is erad-
icated in approximately 20 yr. Again the fact that the
process takes so long does not recommend this vaccina-
tion strategy for control.
C. Comparison of specific features with real data
The strategy given by Eq. (41) was actually adopted in
the United States in 1969 [1]. The results of the impact
on the incidence is shown in Fig. 10 (left-hand scale)
together with the results of our simulation (right-hand
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FIG. 6: (a) Simulations for λ(a, t), without vaccination, con-
sidering a completely susceptible population, at time t = 0,
except for a proportion 10−5 of individuals with ages between
40 and 45 yr that suddenly become infected; (b) the same as
(a), but with the time scale starting at t = 5 yr, so that the
initial peak is cut and the resulting steady state is observable.
scale) for a ν that results in a 80% coverage. The model
estimates for the number of new infections per 100 000
population were calculated according to the following
equation:
Y (t) =
1
N
∫
∞
0
da λ(a, t)S(a, t) , (52)
where
∫
∞
0
da λ(a, t)S(a, t) is the number of new cases per
unit time at time t. In the calculations, the upper limit
of the above integral was taken to be 60 yr.
It should be noted that the incidence calculated from
the seroprevalence data is two orders of magnitude larger
than the incidence that results from notification. In fact,
it is known that only a fraction of all infections display
the clinical features of rubella disease. In addition, only a
fraction of those rubella cases is officially notified. How-
ever, several qualitative features of the data are quite
similar to those observed in the simulations described in
the preceding section. Let us comment, in more detail,
on the more significant similarities.
In 1977, that is, 8 yr after the introduction of the pro-
gram, it was noted that although the program was hav-
ing a major impact on rubella in children, rubella rates
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FIG. 7: Profile of Fig. 6, cut at 8 yr age. The initial outbreak
peak between t = 0 and t = 3 yr almost exhausts the suscepti-
ble fraction of the population. It takes about 3.5 years for the
number of new susceptibles to accumulate in sufficient num-
ber to trigger a second outbreak which eventually stabilizes
at an endemic steady state.
in those older than 15 yr were not substantially different
from prevaccination rates. We shall see now that this
effect is shown in our simulations.
Figure 11 represents four cuts of Fig. 8, corresponding
to 70% coverage, at the ages of 8, 16, 25 and 35 yr. It
can be seen that the above mentioned effect is clearly
observed. The drop in the force of infection at the age of
8 yr is much larger than at 16 and 25 yr, and the effect
at the age of 35 yr is almost negligible.
However, about 15 years after the introduction of the
vaccine, three major outbreaks are observed in the sim-
ulations, and this may be dangerous. The pattern of
several oscillations in the incidence of an infectious dis-
ease, after the introduction of vaccination, has already
been observed in real data [23]. If the vaccinal coverage
is increased to 80%, after small outbreaks, the disease
disappears, as shown in Fig. 9.
V. SUMMARY
In this paper, we analyzed the temporal evolution of
the age-dependent force of infection and incidence of
rubella, after the introduction of a very specific vaccina-
tion program in a previously nonvaccinated population
where rubella was in an endemic steady state. This very
specific vaccination program consists in vaccinating chil-
dren within a certain age range with a rate determined
essentially by the public response to government adver-
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FIG. 8: Simulations for λ(a, t), with the same initial condi-
tions considered in Fig. 6, but including a vaccination routine
of form (41), with a0 = 1 yr, a1 = 2 yr, t0 = 40 yr, and a
vaccination coverage of 70%.
tisements.
We conclude that a simple vaccination program is not
very efficient (very slow) in the goal of eradicating the
disease. This gives support to a mixed strategy proposed
by Massad et al. [2], accepted and implemented by the
government of the State of Sa˜o Paulo. This strategy rec-
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FIG. 9: Vaccination scheme considered in the simulations of
Fig. 8, but with a vaccination coverage of 80%.
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ommended a mass vaccination campaign against rubella
in the State of Sa˜o Paulo for all children with ages be-
tween 1 and 10 yr as an initial intervention followed by
a vaccination program of the form given by (41), in the
routine calendar at 15 months of age. As reported in
Refs. [5, 13], the results were very good, and there was a
considerable reduction in the number of rubella and con-
genital rubella syndrome cases. The incidence of rubella
and CRS remained at low levels with the routine vacci-
nation program, in agreement with our simulation results
for high vaccination coverages.
We have also applied a formalism developed elsewhere
[6] to calculate the effects of vaccination routines de-
signed to reduce or eliminate rubella.
This formalism provides an integral equation for the
force of infection in a steady state given the pattern of
contacts between the members of the population and the
specific form of the vaccination routines.
To apply the formalism, the pattern of contacts be-
tween the members of the population, the so-called con-
tact function β(a, a′), has to be estimated. Some sym-
metries obeyed by β(a, a′) and a general form for it were
studied in Sec. II B. In Sec. III, the force of infection in
the absence of the vaccination was calculated from sero-
prevalence data from four communities in Brazil, Mex-
ico, Finland and the United Kingdom. With this force
of infection, in the absence of vaccination, the contact
function β(a, a′) for each community was estimated. It
was noted that β(a, a′) differed considerably between the
communities studied, which is in agreement with the dif-
ferences in the force of infection in the absence of vacci-
nation.
Finally, in Sec. IVA, the effects of several vaccina-
tion routines were calculated for the four communities
studied. As a general conclusion, one can say that vac-
cination between 1 and 2 yr presents distinct advantages
over any other strategy considered. In Caieiras, vacci-
nation between 7 and 8 yr has the apparent advantage
of shifting the average age of the first infection leftwards.
However, if the coverage is above 60%, the impact of vac-
cinating between 1 and 2 yr on the force of infection is
twice as high as vaccinating between 7 and 8 yr. This re-
sult confirms our previous analysis and recommendations
of 1992 (Massad et al. [2]). In all other communities
studied, vaccination between 7 and 8 yr results in very
disappointing impact when compared with vaccination
between 1 and 2 yr.
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